Absci (ABSI) Financials

$2.66 0.00 (0.00%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$2.64 -0.02 (-0.56%)

As of 05/23/2025 07:57 PM Eastern

Annual Income Statements for Absci

This table shows Absci's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-103	-111	-105
Consolidated Net Income / (Loss)	-103	-111	-105
Net Income / (Loss) Continuing Operations	-103	-111	-105
Total Pre-Tax Income	-103	-110	-105
Total Operating Income	-109	-116	-107
Total Gross Profit	4.53	5.72	5.75
Total Revenue	4.53	5.72	5.75
Operating Revenue	4.53	5.72	5.75
Total Cost of Revenue	0.00	0.00	0.00
Total Operating Expenses	113	121	112
Selling, General & Admin Expense	36	38	41
Research & Development Expense	64	48	59
Depreciation Expense	13	14	13
Impairment Charge	0.00	21	0.00
Total Other Income / (Expense), net	5.85	5.05	1.39
Interest Expense	0.57	1.01	0.97
Other Income / (Expense), net	6.42	6.06	2.36
Income Tax Expense	0.07	0.10	-0.46
Basic Earnings per Share	($0.94)	($1.20)	($1.15)
Weighted Average Basic Shares Outstanding	110.24M	92.03M	90.85M
Diluted Earnings per Share	($0.94)	($1.20)	($1.15)
Weighted Average Diluted Shares Outstanding	110.24M	92.03M	90.85M
Weighted Average Basic & Diluted Shares Outstanding	127.33M	112.78M	92.32M

This table shows Absci's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-29	-27	-25	-22	-24	-22	-42	-23	-19	-27
Consolidated Net Income / (Loss)	-29	-27	-25	-22	-24	-22	-42	-23	-19	-27
Net Income / (Loss) Continuing Operations	-29	-27	-25	-22	-24	-22	-42	-23	-19	-27
Total Pre-Tax Income	-29	-27	-25	-22	-23	-22	-42	-23	-20	-28
Total Operating Income	-30	-29	-27	-23	-25	-23	-43	-24	-21	-28
Total Gross Profit	0.67	1.70	1.27	0.90	0.34	0.74	3.37	1.27	1.56	2.37
Total Revenue	0.67	1.70	1.27	0.90	0.34	0.74	3.37	1.27	1.56	2.37
Operating Revenue	0.67	1.70	1.27	0.90	0.34	0.74	3.37	1.27	1.56	2.37
Total Operating Expenses	30	31	28	24	25	24	46	26	23	30
Selling, General & Admin Expense	8.83	9.26	9.35	8.74	9.32	9.51	9.41	9.59	7.75	11
Research & Development Expense	18	18	15	12	12	11	12	13	11	16
Depreciation Expense	3.23	3.36	3.38	3.42	3.48	3.51	3.50	3.50	3.59	3.40
Total Other Income / (Expense), net	0.81	1.53	1.97	1.54	1.24	1.34	1.33	1.14	1.12	0.40
Interest Expense	0.11	0.13	0.15	0.18	0.20	0.23	0.26	0.32	0.29	0.28
Other Income / (Expense), net	0.92	1.66	2.12	1.71	1.45	1.57	1.58	1.46	1.41	0.68
Income Tax Expense	0.02	0.04	0.00	0.01	0.05	0.03	0.01	0.01	-0.50	-0.31
Basic Earnings per Share	($0.26)	($0.24)	($0.22)	($0.22)	($0.25)	($0.24)	($0.45)	($0.26)	($0.20)	($0.30)
Weighted Average Basic Shares Outstanding	110.24M	113.61M	112.93M	99.39M	92.03M	92.22M	91.83M	91.48M	90.85M	91.11M
Diluted Earnings per Share	($0.26)	($0.24)	($0.22)	($0.22)	($0.25)	($0.24)	($0.45)	($0.26)	($0.20)	($0.30)
Weighted Average Diluted Shares Outstanding	110.24M	113.61M	112.93M	99.39M	92.03M	92.22M	91.83M	91.48M	90.85M	91.11M
Weighted Average Basic & Diluted Shares Outstanding	127.33M	114.86M	113.56M	113.08M	112.78M	92.94M	92.71M	92.50M	92.32M	92.39M

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-31	13	-203
Net Cash From Operating Activities	-72	-65	-81
Net Cash From Continuing Operating Activities	-72	-65	-81
Net Income / (Loss) Continuing Operations	-103	-111	-105
Consolidated Net Income / (Loss)	-103	-111	-105
Depreciation Expense	13	14	13
Amortization Expense	-3.74	-2.67	-0.69
Non-Cash Adjustments To Reconcile Net Income	19	33	13
Changes in Operating Assets and Liabilities, net	1.61	1.85	-1.32
Net Cash From Investing Activities	-42	82	-127
Net Cash From Continuing Investing Activities	-42	82	-127
Purchase of Property, Plant & Equipment	-0.40	-0.86	-16
Purchase of Investments	-186	-147	-109
Sale of Property, Plant & Equipment	0.94	0.25	0.13
Sale and/or Maturity of Investments	144	230	5.00
Net Cash From Financing Activities	83	-4.48	5.24
Net Cash From Continuing Financing Activities	83	-4.48	5.24
Repayment of Debt	-3.39	-3.01	-4.65
Issuance of Common Equity	87	0.86	0.66
Other Financing Activities, net	-0.64	-2.33	-2.80
Cash Interest Paid	0.56	0.97	0.90

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	3.07	-5.44	-16	-13	2.80	8.85	50	-49	-47	-99
Net Cash From Operating Activities	-17	-21	-17	-18	-15	-10	-19	-20	-19	-19
Net Cash From Continuing Operating Activities	-17	-21	-17	-18	-15	-10	-19	-20	-19	-19
Net Income / (Loss) Continuing Operations	-29	-27	-25	-22	-24	-22	-42	-23	-19	-27
Consolidated Net Income / (Loss)	-29	-27	-25	-22	-24	-22	-42	-23	-19	-27
Depreciation Expense	3.23	3.36	3.38	3.42	3.48	3.51	3.50	3.50	3.59	3.40
Amortization Expense	-0.78	-1.12	-1.21	-0.63	-0.40	-0.63	-0.81	-0.83	-0.69	-
Non-Cash Adjustments To Reconcile Net Income	5.07	5.52	5.28	3.59	3.18	2.56	24	2.65	1.02	3.57
Changes in Operating Assets and Liabilities, net	4.50	-1.09	0.46	-2.26	2.36	6.19	-4.61	-2.09	-3.02	1.25
Net Cash From Investing Activities	19	15	1.26	-77	19	20	70	-27	-30	-79
Net Cash From Continuing Investing Activities	19	15	1.26	-77	19	20	70	-27	-30	-79
Purchase of Property, Plant & Equipment	-0.02	-0.05	-0.33	0.00	-0.02	-0.31	-0.26	-0.28	-0.56	-4.87
Purchase of Investments	-27	-28	-34	-97	-25	-30	-24	-69	-35	-74
Sale of Property, Plant & Equipment	0.70	0.10	-	0.15	0.13	0.01	0.07	0.05	0.12	-
Sale and/or Maturity of Investments	45	43	36	21	44	50	94	42	5.00	-
Net Cash From Financing Activities	0.99	0.49	-0.13	81	-1.24	-0.92	-1.22	-1.10	1.39	-0.92
Net Cash From Continuing Financing Activities	0.99	0.49	-0.13	81	-1.24	-0.92	-1.22	-1.10	1.39	-0.92
Repayment of Debt	-0.90	-0.82	-0.80	-0.87	-0.84	-0.76	-0.75	-0.66	-0.57	-0.39
Issuance of Common Equity	1.95	1.39	0.76	82	0.14	0.38	0.12	0.23	0.07	0.16
Other Financing Activities, net	-0.07	-0.08	-0.09	-0.40	-0.53	-0.54	-0.59	-0.67	-0.73	-0.70

This table presents Absci's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	214	217	321
Total Current Assets	134	121	187
Cash & Equivalents	41	72	60
Restricted Cash	16	16	15
Short-Term Investments	71	25	104
Accounts Receivable	0.00	2.19	-
Prepaid Expenses	5.46	4.54	5.86
Plant, Property, & Equipment, net	0.00	0.00	0.00
Total Noncurrent Assets	80	97	134
Intangible Assets	45	48	52
Other Noncurrent Operating Assets	35	48	61
Total Liabilities & Shareholders' Equity	214	217	321
Total Liabilities	34	41	47
Total Current Liabilities	29	30	30
Short-Term Debt	15	16	2.95
Accounts Payable	3.53	1.50	2.41
Accrued Expenses	6.84	6.55	20
Current Deferred Revenue	1.12	3.17	0.45
Other Current Liabilities	1.69	2.32	3.99
Total Noncurrent Liabilities	5.82	12	16
Long-Term Debt	1.26	4.66	7.98
Capital Lease Obligations	4.43	5.64	0.75
Noncurrent Deferred Revenue	0.00	0.97	0.00
Other Noncurrent Operating Liabilities	0.13	0.30	7.35
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	179	176	274
Total Preferred & Common Equity	179	176	274
Preferred Stock	0.00	0.00	0.00
Total Common Equity	179	176	274
Common Stock	689	583	570
Retained Earnings	-510	-406	-296
Accumulated Other Comprehensive Income / (Loss)	-0.00	-0.04	-0.12

This table presents Absci's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	235	256	275	236	254	296	339
Total Current Assets	150	165	182	135	148	165	201
Cash & Equivalents	38	43	59	70	61	11	107
Restricted Cash	16	17	16	16	15	15	15
Short-Term Investments	89	102	103	44	64	133	74
Note & Lease Receivable	1.50	0.04	0.04	0.80	3.16	1.33	0.21
Prepaid Expenses	5.78	3.39	3.86	4.40	5.23	4.71	4.84
Plant, Property, & Equipment, net	0.00	0.00	39	0.00	0.00	50	0.00
Total Noncurrent Assets	85	90	54	102	106	80	138
Intangible Assets	46	47	47	49	50	51	52
Other Noncurrent Operating Assets	39	44	6.93	53	56	8.21	64
Total Liabilities & Shareholders' Equity	235	256	275	236	254	296	339
Total Liabilities	34	34	35	40	39	42	46
Total Current Liabilities	27	25	25	28	25	27	30
Short-Term Debt	3.27	3.12	3.30	3.21	3.15	3.08	2.35
Accounts Payable	1.67	1.69	1.65	1.91	1.85	1.93	1.86
Accrued Expenses	18	17	15	20	17	18	21
Current Deferred Revenue	1.78	1.97	3.06	0.35	0.50	0.36	0.68
Other Current Liabilities	1.71	1.82	1.87	2.83	3.28	3.74	4.16
Total Noncurrent Liabilities	7.21	8.57	9.50	12	13	15	16
Long-Term Debt	2.16	3.12	3.75	5.55	6.38	7.19	6.52
Capital Lease Obligations	4.85	5.26	5.33	6.16	0.25	7.23	9.11
Noncurrent Deferred Revenue	0.00	0.00	0.18	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	0.18	0.18	0.18	0.25	0.22	0.22	0.76
Other Noncurrent Operating Liabilities	0.03	0.02	0.08	0.00	6.42	0.00	0.03
Total Equity & Noncontrolling Interests	201	221	240	196	215	254	293
Total Preferred & Common Equity	201	221	240	196	215	254	293
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	201	221	240	196	215	254	293
Common Stock	682	675	669	579	577	573	569
Retained Earnings	-481	-453	-428	-383	-361	-319	-276
Accumulated Other Comprehensive Income / (Loss)	0.25	-0.11	-0.13	-0.06	-0.15	-0.10	0.03

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-20.71%	-0.50%	20.18%
EBITDA Growth	5.40%	-6.61%	7.75%
EBIT Growth	6.38%	-4.85%	1.91%
NOPAT Growth	5.74%	-8.21%	-41.88%
Net Income Growth	6.75%	-5.40%	-3.91%
EPS Growth	21.67%	-4.35%	44.71%
Operating Cash Flow Growth	-12.02%	20.54%	-34.23%
Free Cash Flow Firm Growth	5.31%	15.99%	51.30%
Invested Capital Growth	-18.85%	-16.88%	0.09%
Revenue Q/Q Growth	7.77%	-17.57%	1.86%
EBITDA Q/Q Growth	-7.15%	-3.61%	6.62%
EBIT Q/Q Growth	-5.74%	-3.41%	5.76%
NOPAT Q/Q Growth	-4.85%	-3.26%	4.61%
Net Income Q/Q Growth	-5.57%	-3.83%	5.15%
EPS Q/Q Growth	-1.08%	-4.35%	-394.87%
Operating Cash Flow Q/Q Growth	-2.90%	5.34%	-1.86%
Free Cash Flow Firm Q/Q Growth	0.17%	-38.03%	0.00%
Invested Capital Q/Q Growth	4.63%	8.33%	-6.94%
Profitability Metrics	-	-	-
Gross Margin	100.00%	100.00%	100.00%
EBITDA Margin	-2,047.31%	-1,716.12%	-1,601.60%
Operating Margin	-2,401.59%	-2,020.20%	-1,857.49%
EBIT Margin	-2,260.06%	-1,914.24%	-1,816.48%
Profit (Net Income) Margin	-2,274.06%	-1,933.65%	-1,825.37%
Tax Burden Percent	100.07%	100.09%	99.56%
Interest Burden Percent	100.55%	100.92%	100.93%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-94.94%	-82.82%	-70.10%
ROIC Less NNEP Spread (ROIC-NNEP)	-67.33%	-59.55%	-55.98%
Return on Net Nonoperating Assets (RNNOA)	36.90%	33.74%	37.35%
Return on Equity (ROE)	-58.04%	-49.08%	-32.76%
Cash Return on Invested Capital (CROIC)	-74.13%	-64.38%	-70.19%
Operating Return on Assets (OROA)	-47.56%	-40.67%	-27.94%
Return on Assets (ROA)	-47.86%	-41.08%	-28.08%
Return on Common Equity (ROCE)	-58.04%	-49.08%	-32.76%
Return on Equity Simple (ROE_SIMPLE)	-57.56%	-62.76%	-38.23%
Net Operating Profit after Tax (NOPAT)	-76	-81	-75
NOPAT Margin	-1,681.11%	-1,414.14%	-1,300.24%
Net Nonoperating Expense Percent (NNEP)	-27.61%	-23.27%	-14.12%
Return On Investment Capital (ROIC_SIMPLE)	-38.05%	-39.93%	-
Cost of Revenue to Revenue	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	797.84%	661.63%	705.62%
R&D to Revenue	1,408.45%	840.63%	1,025.02%
Operating Expenses to Revenue	2,501.59%	2,120.20%	1,957.49%
Earnings before Interest and Taxes (EBIT)	-102	-109	-104
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-93	-98	-92
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.68	2.22	0.71
Price to Tangible Book Value (P/TBV)	2.24	3.05	0.96
Price to Revenue (P/Rev)	66.37	68.27	33.76
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.69	3.42	0.25
Enterprise Value to Revenue (EV/Rev)	42.73	52.96	4.57
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.12	0.15	0.04
Long-Term Debt to Equity	0.03	0.06	0.03
Financial Leverage	-0.55	-0.57	-0.67
Leverage Ratio	1.21	1.19	1.17
Compound Leverage Factor	1.22	1.21	1.18
Debt to Total Capital	10.57%	12.99%	4.08%
Short-Term Debt to Total Capital	7.73%	7.91%	1.03%
Long-Term Debt to Total Capital	2.84%	5.09%	3.05%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	89.43%	87.01%	95.92%
Debt to EBITDA	-0.23	-0.27	-0.13
Net Debt to EBITDA	1.15	0.89	1.82
Long-Term Debt to EBITDA	-0.06	-0.11	-0.09
Debt to NOPAT	-0.28	-0.33	-0.16
Net Debt to NOPAT	1.41	1.08	2.25
Long-Term Debt to NOPAT	-0.07	-0.13	-0.12
Altman Z-Score	0.93	1.94	0.74
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	4.67	4.08	6.17
Quick Ratio	3.92	3.38	5.48
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-60	-63	-75
Operating Cash Flow to CapEx	0.00%	-10,666.01%	-507.04%
Free Cash Flow to Firm to Interest Expense	-105.34	-62.23	-76.97
Operating Cash Flow to Interest Expense	-128.15	-64.00	-83.68
Operating Cash Flow Less CapEx to Interest Expense	-127.20	-64.60	-100.19
Efficiency Ratios	-	-	-
Asset Turnover	0.02	0.02	0.02
Accounts Receivable Turnover	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	72	89	107
Invested Capital Turnover	0.06	0.06	0.05
Increase / (Decrease) in Invested Capital	-17	-18	0.09
Enterprise Value (EV)	194	303	26
Market Capitalization	301	390	194
Book Value per Share	$1.56	$1.90	$2.97
Tangible Book Value per Share	$1.17	$1.38	$2.18
Total Capital	200	202	286
Total Debt	21	26	12
Total Long-Term Debt	5.69	10	8.73
Net Debt	-107	-88	-168
Capital Expenditures (CapEx)	-0.54	0.61	16
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-7.71	-6.82	-20
Debt-free Net Working Capital (DFNWC)	121	107	160
Net Working Capital (NWC)	105	91	157
Net Nonoperating Expense (NNE)	27	30	30
Net Nonoperating Obligations (NNO)	-107	-88	-168
Total Depreciation and Amortization (D&A)	9.65	11	12
Debt-free, Cash-free Net Working Capital to Revenue	-170.14%	-119.34%	-346.53%
Debt-free Net Working Capital to Revenue	2,661.18%	1,871.77%	2,776.04%
Net Working Capital to Revenue	2,319.70%	1,591.82%	2,724.78%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.94)	($1.20)	($1.15)
Adjusted Weighted Average Basic Shares Outstanding	110.24M	92.03M	90.85M
Adjusted Diluted Earnings per Share	($0.94)	($1.20)	($1.15)
Adjusted Weighted Average Diluted Shares Outstanding	110.24M	92.03M	90.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	127.33M	112.78M	92.32M
Normalized Net Operating Profit after Tax (NOPAT)	-76	-66	-75
Normalized NOPAT Margin	-1,681.11%	-1,152.96%	-1,300.24%
Pre Tax Income Margin	-2,272.52%	-1,931.90%	-1,833.39%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-181.36	-108.37	-107.40
NOPAT to Interest Expense	-134.91	-80.06	-76.88
EBIT Less CapEx to Interest Expense	-180.42	-108.97	-123.90
NOPAT Less CapEx to Interest Expense	-133.96	-80.66	-93.38
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	96.75%	128.63%	-62.28%	-29.24%	-78.29%	-68.59%	236.03%	54.95%	7.23%	53.93%
EBITDA Growth	-30.67%	-32.62%	42.08%	6.65%	-20.37%	21.10%	-51.27%	21.02%	27.98%	-6.88%
EBIT Growth	-23.87%	-25.31%	40.59%	5.39%	-18.33%	20.38%	-44.07%	19.71%	24.49%	-11.08%
NOPAT Growth	-20.35%	-24.00%	37.84%	4.03%	-17.29%	16.68%	-48.81%	14.99%	19.66%	-32.28%
Net Income Growth	-23.10%	-24.57%	40.61%	5.91%	-20.92%	19.31%	-45.30%	20.81%	22.63%	-15.34%
EPS Growth	-4.00%	0.00%	51.11%	15.38%	-25.00%	20.00%	-40.63%	21.21%	-114.93%	9.09%
Operating Cash Flow Growth	-13.68%	-100.10%	12.43%	11.21%	19.64%	45.59%	14.81%	4.87%	-8.72%	12.43%
Free Cash Flow Firm Growth	-701.54%	-143.44%	52.72%	188.33%	104.63%	159.18%	77.17%	80.93%	0.00%	77.05%
Invested Capital Growth	-18.85%	-15.98%	-16.69%	-33.51%	-16.88%	-28.60%	-19.50%	6.45%	0.09%	7.74%
Revenue Q/Q Growth	-60.91%	33.94%	41.43%	165.68%	-54.57%	-77.90%	165.33%	-18.50%	-34.28%	136.43%
EBITDA Q/Q Growth	-5.63%	-11.44%	-18.03%	5.95%	-7.21%	51.33%	-90.23%	-21.26%	29.73%	6.68%
EBIT Q/Q Growth	-5.96%	-10.70%	-12.91%	6.47%	-7.19%	47.52%	-79.81%	-16.98%	27.88%	5.04%
NOPAT Q/Q Growth	-3.04%	-8.14%	-13.72%	5.02%	-6.16%	45.79%	-75.57%	-16.08%	24.58%	3.18%
Net Income Q/Q Growth	-5.79%	-10.70%	-12.63%	6.67%	-7.05%	47.22%	-78.43%	-19.95%	28.57%	4.95%
EPS Q/Q Growth	-8.33%	-9.09%	0.00%	12.00%	-4.17%	46.67%	-73.08%	-30.00%	33.33%	6.25%
Operating Cash Flow Q/Q Growth	18.17%	-23.09%	5.71%	-19.71%	-44.02%	46.13%	4.40%	-8.35%	2.49%	15.66%
Free Cash Flow Firm Q/Q Growth	42.14%	-61.33%	-120.96%	11.25%	-95.82%	275.59%	60.84%	-61.12%	46.58%	32.26%
Invested Capital Q/Q Growth	4.63%	-3.51%	-4.48%	6.07%	8.33%	-4.32%	-23.77%	5.19%	-6.94%	7.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-3,970.08%	-1,469.37%	-1,765.98%	-2,116.04%	-5,977.81%	-2,533.20%	-1,150.01%	-1,604.02%	-1,078.10%	-1,008.36%
Operating Margin	-4,477.29%	-1,698.71%	-2,104.02%	-2,616.70%	-7,319.23%	-3,132.12%	-1,276.74%	-1,929.47%	-1,354.72%	-1,180.54%
EBIT Margin	-4,338.80%	-1,600.88%	-1,937.01%	-2,426.17%	-6,891.42%	-2,920.83%	-1,229.73%	-1,814.58%	-1,264.23%	-1,152.05%
Profit (Net Income) Margin	-4,358.35%	-1,610.70%	-1,948.82%	-2,447.10%	-6,965.98%	-2,956.18%	-1,237.66%	-1,840.43%	-1,250.55%	-1,150.65%
Tax Burden Percent	100.07%	100.14%	100.00%	100.05%	100.20%	100.15%	100.03%	100.03%	97.50%	98.87%
Interest Burden Percent	100.38%	100.48%	100.61%	100.81%	100.88%	101.05%	100.62%	101.39%	101.46%	101.02%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-177.00%	-66.45%	-61.07%	-104.88%	-300.05%	-154.87%	-79.81%	-76.94%	-51.13%	-42.20%
ROIC Less NNEP Spread (ROIC-NNEP)	-168.64%	-60.65%	-56.75%	-101.29%	-295.17%	-150.99%	-73.00%	-73.65%	-48.93%	-38.86%
Return on Net Nonoperating Assets (RNNOA)	92.43%	37.69%	36.39%	63.00%	167.25%	90.39%	46.67%	46.69%	32.64%	26.25%
Return on Equity (ROE)	-84.57%	-28.76%	-24.68%	-41.88%	-132.80%	-64.48%	-33.15%	-30.25%	-18.49%	-15.95%
Cash Return on Invested Capital (CROIC)	-74.13%	-79.20%	-69.55%	-45.60%	-64.38%	-46.37%	-63.47%	-72.17%	-70.19%	0.00%
Operating Return on Assets (OROA)	-91.31%	-28.56%	-24.70%	-45.46%	-146.40%	-70.39%	-33.94%	-32.53%	-19.45%	-16.49%
Return on Assets (ROA)	-91.72%	-28.74%	-24.85%	-45.85%	-147.99%	-71.24%	-34.16%	-33.00%	-19.24%	-16.47%
Return on Common Equity (ROCE)	-84.57%	-28.76%	-24.68%	-41.88%	-132.80%	-64.48%	-33.15%	-30.25%	-18.49%	-15.95%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-48.51%	-41.66%	-45.47%	0.00%	-54.22%	-51.88%	-38.89%	0.00%	-37.75%
Net Operating Profit after Tax (NOPAT)	-21	-20	-19	-16	-17	-16	-30	-17	-15	-20
NOPAT Margin	-3,134.11%	-1,189.09%	-1,472.81%	-1,831.69%	-5,123.46%	-2,192.49%	-893.72%	-1,350.63%	-948.30%	-826.38%
Net Nonoperating Expense Percent (NNEP)	-8.36%	-5.80%	-4.32%	-3.60%	-4.88%	-3.88%	-6.82%	-3.30%	-2.20%	-3.34%
Return On Investment Capital (ROIC_SIMPLE)	-10.41%	-	-	-	-8.55%	-	-	-	-	-
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	1,327.52%	544.15%	735.91%	973.72%	2,758.58%	1,277.55%	279.48%	755.95%	497.69%	481.51%
R&D to Revenue	2,763.46%	1,057.32%	1,201.65%	1,362.58%	3,629.88%	1,482.39%	359.73%	997.40%	726.72%	655.34%
Operating Expenses to Revenue	4,577.29%	1,798.71%	2,204.02%	2,716.70%	7,419.23%	3,232.12%	1,376.74%	2,029.47%	1,454.72%	1,280.54%
Earnings before Interest and Taxes (EBIT)	-29	-27	-25	-22	-23	-22	-41	-23	-20	-27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-26	-25	-22	-19	-20	-19	-39	-20	-17	-24
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.68	2.15	1.57	2.67	2.22	0.62	0.65	0.64	0.71	0.99
Price to Tangible Book Value (P/TBV)	2.24	2.79	1.99	3.32	3.05	0.83	0.85	0.89	0.96	1.33
Price to Revenue (P/Rev)	66.37	103.11	107.17	119.81	68.27	17.64	16.42	26.07	33.76	51.51
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.69	4.38	2.78	6.37	3.42	0.10	0.13	0.18	0.25	0.98
Enterprise Value to Revenue (EV/Rev)	42.73	71.59	60.94	88.85	52.96	1.12	1.25	3.19	4.57	19.90
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.12	0.05	0.05	0.05	0.15	0.08	0.05	0.07	0.04	0.06
Long-Term Debt to Equity	0.03	0.03	0.04	0.04	0.06	0.06	0.03	0.06	0.03	0.05
Financial Leverage	-0.55	-0.62	-0.64	-0.62	-0.57	-0.60	-0.64	-0.63	-0.67	-0.68
Leverage Ratio	1.21	1.19	1.17	1.16	1.19	1.18	1.17	1.16	1.17	1.16
Compound Leverage Factor	1.22	1.19	1.17	1.16	1.21	1.19	1.17	1.18	1.18	1.17
Debt to Total Capital	10.57%	4.86%	4.94%	4.90%	12.99%	7.06%	4.34%	6.45%	4.08%	5.78%
Short-Term Debt to Total Capital	7.73%	1.55%	1.34%	1.31%	7.91%	1.52%	1.40%	1.13%	1.03%	0.76%
Long-Term Debt to Total Capital	2.84%	3.31%	3.60%	3.59%	5.09%	5.54%	2.94%	5.31%	3.05%	5.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	89.43%	95.14%	95.06%	95.10%	87.01%	92.94%	95.66%	93.55%	95.92%	94.22%
Debt to EBITDA	-0.23	-0.12	-0.14	-0.13	-0.27	-0.16	-0.10	-0.20	-0.13	-0.18
Net Debt to EBITDA	1.15	1.53	1.87	1.71	0.89	1.21	1.30	1.64	1.82	1.81
Long-Term Debt to EBITDA	-0.06	-0.08	-0.10	-0.09	-0.11	-0.12	-0.07	-0.17	-0.09	-0.16
Debt to NOPAT	-0.28	-0.14	-0.17	-0.15	-0.33	-0.19	-0.12	-0.24	-0.16	-0.23
Net Debt to NOPAT	1.41	1.82	2.18	2.06	1.08	1.46	1.59	1.98	2.25	2.28
Long-Term Debt to NOPAT	-0.07	-0.10	-0.12	-0.11	-0.13	-0.15	-0.08	-0.20	-0.12	-0.20
Altman Z-Score	2.06	5.08	4.01	9.31	3.25	-0.16	0.26	1.13	1.61	2.97
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.67	5.63	6.49	7.19	4.08	4.82	5.81	6.08	6.17	6.71
Quick Ratio	3.92	4.82	5.71	6.39	3.38	4.09	5.01	5.35	5.48	6.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4.14	-7.15	-4.43	21	0.69	16	-9.37	-24	-15	-28
Operating Cash Flow to CapEx	0.00%	0.00%	-5,057.96%	0.00%	0.00%	-3,500.34%	-10,070.16%	-8,824.12%	-4,200.91%	-391.03%
Free Cash Flow to Firm to Interest Expense	-37.95	-55.00	-29.54	120.13	3.37	71.87	-36.62	-74.57	-51.76	-99.68
Operating Cash Flow to Interest Expense	-155.63	-159.48	-112.29	-101.49	-73.15	-45.24	-75.13	-62.68	-64.70	-68.25
Operating Cash Flow Less CapEx to Interest Expense	-149.47	-159.12	-114.51	-100.65	-72.61	-46.54	-75.88	-63.39	-66.24	-85.71
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.02	0.02	0.01	0.02	0.02	0.02	0.03	0.02	0.02	0.01
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.12	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	72	69	71	75	89	82	86	112	107	115
Invested Capital Turnover	0.06	0.06	0.04	0.06	0.06	0.07	0.09	0.06	0.05	0.05
Increase / (Decrease) in Invested Capital	-17	-13	-14	-38	-18	-33	-21	6.80	0.09	8.23
Enterprise Value (EV)	194	301	198	475	303	7.78	11	20	26	112
Market Capitalization	301	434	348	641	390	122	141	162	194	291
Book Value per Share	$1.56	$1.77	$1.96	$2.13	$1.90	$2.12	$2.35	$2.75	$2.97	$3.16
Tangible Book Value per Share	$1.17	$1.37	$1.55	$1.71	$1.38	$1.59	$1.80	$1.97	$2.18	$2.36
Total Capital	200	212	233	252	202	211	225	271	286	311
Total Debt	21	10	12	12	26	15	9.77	17	12	18
Total Long-Term Debt	5.69	7.00	8.38	9.07	10	12	6.62	14	8.73	16
Net Debt	-107	-133	-150	-166	-88	-115	-130	-142	-168	-178
Capital Expenditures (CapEx)	-0.67	-0.05	0.33	-0.15	-0.11	0.30	0.19	0.23	0.44	4.87
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-7.71	-16	-19	-18	-6.82	-20	-14	-18	-20	-23
Debt-free Net Working Capital (DFNWC)	121	127	143	160	107	110	126	141	160	174
Net Working Capital (NWC)	105	123	140	157	91	107	123	138	157	171
Net Nonoperating Expense (NNE)	8.14	7.17	6.05	5.53	6.23	5.68	12	6.22	4.71	7.68
Net Nonoperating Obligations (NNO)	-107	-133	-150	-166	-88	-115	-130	-142	-168	-178
Total Depreciation and Amortization (D&A)	2.45	2.24	2.17	2.79	3.09	2.88	2.68	2.67	2.90	3.40
Debt-free, Cash-free Net Working Capital to Revenue	-170.14%	-383.58%	-581.88%	-338.17%	-119.34%	-281.98%	-162.99%	-291.93%	-346.53%	-401.01%
Debt-free Net Working Capital to Revenue	2,661.18%	3,012.36%	4,395.17%	2,988.80%	1,871.77%	1,585.02%	1,468.09%	2,278.43%	2,776.04%	3,078.82%
Net Working Capital to Revenue	2,319.70%	2,934.54%	4,299.05%	2,927.06%	1,591.82%	1,538.71%	1,431.36%	2,228.76%	2,724.78%	3,037.10%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.26)	($0.24)	($0.22)	($0.22)	($0.25)	($0.24)	($0.45)	($0.26)	($0.20)	($0.30)
Adjusted Weighted Average Basic Shares Outstanding	110.24M	113.61M	112.93M	99.39M	92.03M	92.22M	91.83M	91.48M	90.85M	91.11M
Adjusted Diluted Earnings per Share	($0.26)	($0.24)	($0.22)	($0.22)	($0.25)	($0.24)	($0.45)	($0.26)	($0.20)	($0.30)
Adjusted Weighted Average Diluted Shares Outstanding	110.24M	113.61M	112.93M	99.39M	92.03M	92.22M	91.83M	91.48M	90.85M	91.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	127.33M	114.86M	113.56M	113.08M	112.78M	92.94M	92.71M	92.50M	92.32M	92.39M
Normalized Net Operating Profit after Tax (NOPAT)	-21	-20	-19	-16	-17	-16	-15	-17	-15	-20
Normalized NOPAT Margin	-3,134.11%	-1,189.09%	-1,472.81%	-1,831.69%	-5,123.46%	-2,192.49%	-450.17%	-1,350.63%	-948.30%	-826.38%
Pre Tax Income Margin	-4,355.19%	-1,608.52%	-1,948.82%	-2,445.77%	-6,951.78%	-2,951.61%	-1,237.33%	-1,839.87%	-1,282.66%	-1,163.82%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-264.71	-209.47	-164.00	-123.79	-114.18	-94.90	-161.74	-71.74	-68.59	-97.82
NOPAT to Interest Expense	-191.21	-155.59	-124.70	-93.46	-84.89	-71.23	-117.55	-53.39	-51.45	-70.17
EBIT Less CapEx to Interest Expense	-258.54	-209.11	-166.22	-122.94	-113.65	-96.19	-162.48	-72.45	-70.13	-115.28
NOPAT Less CapEx to Interest Expense	-185.04	-155.23	-126.92	-92.61	-84.35	-72.52	-118.29	-54.10	-52.99	-87.62
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Absci's Financials

When does Absci's fiscal year end?

According to the most recent income statement we have on file, Absci's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Absci's net income changed over the last 2 years?

The last 5 years of Absci's net income performance:

2022: -$104.90 million
2023: -$110.57 million
2024: -$103.11 million

Find out what analysts predict for Absci in the coming months.

What is Absci's operating income?

Absci's total operating income in 2024 was -$108.89 million, based on the following breakdown:

Total Gross Profit: $4.53 million
Total Operating Expenses: $113.42 million

How has Absci revenue changed over the last 2 years?

Over the last 2 years, Absci's total revenue changed from $5.75 million in 2022 to $4.53 million in 2024, a change of -21.1%.

How much debt does Absci have?

Absci's total liabilities were at $34.48 million at the end of 2024, a 16.2% decrease from 2023, and a 26.0% decrease since 2022.

How much cash does Absci have?

In the past 2 years, Absci's cash and equivalents has ranged from $41.21 million in 2024 to $72.36 million in 2023, and is currently $41.21 million as of their latest financial filing in 2024.

How has Absci's book value per share changed over the last 2 years?

Over the last 2 years, Absci's book value per share changed from 2.97 in 2022 to 1.56 in 2024, a change of -47.5%.

Related Companies

This page (NASDAQ:ABSI) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Absci (ABSI) Financials

Frequently Asked Questions About Absci's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Absci (ABSI) Financials

Annual Income Statements for Absci

Quarterly Income Statements for Absci

Annual Cash Flow Statements for Absci

Quarterly Cash Flow Statements for Absci

Annual Balance Sheets for Absci

Quarterly Balance Sheets for Absci

Annual Metrics And Ratios for Absci

Quarterly Metrics And Ratios for Absci

Frequently Asked Questions About Absci's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools